ECM Therapeutics

Stephen Badylak, DVM, PhD, MD is a Professor in the Department of Surgery, and Deputy. Badylak is a Fellow of the American Institute for Medical and Biological Engineering, a member of the Society for Biomaterials, a charter member of the Tissue Engineering Society International, a past president of the Tissue Engineering Regenerative Medicine International Society (TERMIS) and a Founding International Fellow of TERMIS. Paul commenced serving as the Chief Executive Officer of ECM Therapeutics since April, 2018. Prior to ECM Therapeutics, in 2000 Paul co-founded and served as Executive Vice President and General Counsel of Three Rivers Pharmaceuticals, LLC (“3RP”) as well as being a member of its Board of Directors. At the time of its acquisition, 3RP operated in the United States and 48 countries world-wide. Prior to co-founding ECM Therapeutics, Katie founded and remains President of KLC Connections, a business development and marketing firm that specializes in biotechnology and medical industries. Craig Venter, who is known for sequencing the human genome, to lead the fundraising efforts of the J. Dziki has served as VP of Product Development for ECM Therapeutics since April of 2018.